KDI · Dialyzer, High Permeability With Or Without Sealed Dialysate System
Gastroenterology, Urology · 21 CFR 876.5860 · Class 2
Overview
| Product Code | KDI |
|---|---|
| Device Name | Dialyzer, High Permeability With Or Without Sealed Dialysate System |
| Regulation | 21 CFR 876.5860 |
| Device Class | Class 2 |
| Review Panel | Gastroenterology, Urology |
| Life-Sustaining | Yes |
Identification
A high permeability hemodialysis system is a device intended for use as an artificial kidney system for the treatment of patients with renal failure, fluid overload, or toxemic conditions by performing such therapies as hemodialysis, hemofiltration, hemoconcentration, and hemodiafiltration. Using a hemodialyzer with a semipermeable membrane that is more permeable to water than the semipermeable membrane of the conventional hemodialysis system (§ 876.5820), the high permeability hemodialysis system removes toxins or excess fluid from the patient's blood using the principles of convection (via a high ultrafiltration rate) and/or diffusion (via a concentration gradient in dialysate). During treatment, blood is circulated from the patient through the hemodialyzer's blood compartment, while the dialysate solution flows countercurrent through the dialysate compartment. In this process, toxins and/or fluid are transferred across the membrane from the blood to the dialysate compartment. The hemodialysis delivery machine controls and monitors the parameters related to this processing, including the rate at which blood and dialysate are pumped through the system, and the rate at which fluid is removed from the patient. The high permeability hemodialysis system consists of the following devices:(1) The hemodialyzer consists of a semipermeable membrane with an in vitro ultrafiltration coefficient (K uf ) greater than 8 milliliters per hour per conventional millimeter of mercury, as measured with bovine or expired human blood, and is used with either an automated ultrafiltration controller or anther method of ultrafiltration control to prevent fluid imbalance.(2) The hemodialysis delivery machine is similar to the extracorporeal blood system and dialysate delivery system of the hemodialysis system and accessories (§ 876.5820), with the addition of an ultrafiltration controller and mechanisms that monitor and/or control such parameters as fluid balance, dialysate composition, and patient treatment parameters (e.g., blood pressure, hematocrit, urea, etc.). (3) The high permeability hemodialysis system accessories include, but are not limited to, tubing lines and various treatment related monitors (e.g., dialysate pH, blood pressure, hematocrit, and blood recirculation monitors).
Classification Rationale
Class II. The special controls for this device are FDA's:
Special Controls
*Classification.* Class II. The special controls for this device are FDA's:(1) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Device—Part I: Evaluation and Testing,’ ” (2) “Guidance for the Content of 510(k)s for Conventional and High Permeability Hemodialyzers,” (3) “Guidance for Industry and CDRH Reviewers on the Content of Premarket Notifications for Hemodialysis Delivery Systems,” (4) “Guidance for the Content of Premarket Notifications for Water Purification Components and Systems for Hemodialysis,” and (5) “Guidance for Hemodialyzer Reuse Labeling.”
Recent Cleared Devices (20 of 343)
Showing 20 most recent of 343 cleared devices.
| Record | Device Name | Applicant | Decision Date | Decision |
|---|---|---|---|---|
| K260533 | ELISIO-H | Nipro Medical Corporation | Mar 19, 2026 | SESE |
| K252459 | multiFlux 130 (F00013123); multiFlux 160 (F00013124) | Fresenius Medical Care Renal Therapies Group, LLC | Feb 10, 2026 | SESE |
| K253412 | Tablo Hemodialysis System (PN-0008000, PN-0006000U) | Outset Medical, Inc. | Jan 26, 2026 | SESE |
| K253518 | FX CorAL 40; FX CorAL 50 | Fresenius Medical Care Renal Therapies Group, LLC | Dec 18, 2025 | SESE |
| K243920 | Purema H Hemoconcentrator - Pediatric | Medica USA, Inc. | Sep 19, 2025 | SESE |
| K250508 | AK 98 Dialysis Machine (955607) | Vantive US Healthcare, LLC | Aug 1, 2025 | SESE |
| K243237 | 2008T HD SYS. CDX BLUESTAR (191124); 2008T HD SYS. CDX W/bibag BLUESTAR (191126); 2008T HD SYS. W/O CDX BLUESTAR (191128); 2008T HD SYS. W/O CDX W/bibag BLUESTAR (191130) | Fresenius Medical Care Renal Therapies Group, LLC | Jun 13, 2025 | SESE |
| K243505 | 5008X Hemodialysis System | Fresenius Medical Care Renal Therapies Group, LLC | May 30, 2025 | SESE |
| K242155 | DBB-06 PRO Hemodialysis Delivery System (DBB-06 PRO) | NIKKISO CO., LTD. | May 15, 2025 | SESE |
| K243264 | DHF 0.2 Hemoconcentrator (DHF 02); DHF 0.6 Hemoconcentrator (DHF 06); SH 14 Hemoconcentrator (SH 14) | Sorin Group Italia S.R.L. | Apr 25, 2025 | SESE |
| K242053 | FX CorAL 40 (F00009214); FX CorAL 50 (F00009215) | Fresenius Medical Care Renal Therapies Group, LLC | Mar 21, 2025 | SESE |
| K243874 | FX CorAL 60 (F00012969); FX CorAL 80 (F00012970); FX CorAL 100 (F00012971); FX CorAL 120 (F00012972); FX CorAL 600 (F00012973); FX CorAL 800 (F00012974); FX CorAL 1000 (F00012975) | Fresenius Medical Care Renal Therapies Group, LLC | Feb 28, 2025 | SESE |
| K233798 | Moda-flx Hemodialysis System and Cartridge | Diality, Inc. | Aug 2, 2024 | SESE |
| K233557 | HemoCare Hemodialysis System | Deka Research and Development | Jul 12, 2024 | SESE |
| K240394 | multiFlux 1000 (F00012408) | Fresenius Medical Care Renal Therapies Group, LLC | May 31, 2024 | SESE |
| K232776 | Tablo® Hemodialysis System; TabloCart with Prefiltration Drawer | Outset Medical, Inc. | May 3, 2024 | SESE |
| K232803 | NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E) | Nxstage Medical, Inc. | Mar 14, 2024 | SESE |
| K232171 | Purema® H Hemoconcentrator (EtO Sterilized) | Tecnoideal America | Feb 7, 2024 | SESE |
| K231534 | 5008X Hemodialysis System | Fresenius Medical Care | Feb 2, 2024 | SESE |
| K231125 | 2008T BlueStar Hemodialysis Machine | Fresenius Medical Care Renal Therapies Group, LLC | Dec 6, 2023 | SESE |
Top Applicants
- Nxstage Medical, Inc. — 26 clearances
- Hospal Medical Corp. — 20 clearances
- Althin Medical AB an Affiliate of Baxter Intl — 18 clearances
- Baxter Healthcare Corp — 18 clearances
- Fresenius Medical Care North America — 17 clearances